Literature DB >> 31401046

SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.

Sitong Zhou1, Yanhua Liang2, Xi Zhang1, Lexi Liao1, Yao Yang1, Wen Ouyang3, Huaiyuan Xu4.   

Abstract

SHARPIN, as a tumor-associated gene, is involved in the metastatic process of many kinds of tumors. Herein, we studied the function of Shank-associated RH domain interacting protein (SHARPIN) in melanoma metastasis and the relevant molecular mechanisms. We found that SHARPIN expression was increased in melanoma tissues and activated the process of proliferation, migration, and invasion in vitro and in vivo, resulting in a poor prognosis of the disease. Functional analysis demonstrated that SHARPIN promoted melanoma migration and invasion by regulating Ras-associated protein-1(Rap1) and its downstream pathways, including p38 and JNK/c-Jun. Rap1 activator (8-pCPT-2'-O-Me-cAMP) and inhibitor (ESI-09 and farnesylthiosalicylic acid-amide) treatments could partially rescue invasion and migration of tumor cells. Additionally, SHARPIN expression in cell lines and public datasets also indicated that molecules other than BRAF and N-RAS may contribute to SHARPIN activation. In conclusion, our broad-in-depth work suggests that SHARPIN promotes melanoma development via p38 and JNK/c-Jun pathways through upregulation of Rap1 expression.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31401046     DOI: 10.1016/j.jid.2019.07.696

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis.

Authors:  Jinzhi Meng; Xing Huang; Yue Qiu; Miao Yu; Jinfeng Lu; Jun Yao
Journal:  Int J Gen Med       Date:  2021-09-07

Review 2.  Advances in the Structural and Physiological Functions of SHARPIN.

Authors:  Beiming Yu; Feng Wang; Yanfeng Wang
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

3.  Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.

Authors:  Mei Chen; Xin Gao; Denggao Huang; Shunlan Wang; Linlin Zheng; Yinyi Chen; Xiaohong Wen; Yuanhui Gao; Hui Cao; Shufang Zhang
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

4.  SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer.

Authors:  Juanjuan He; Jing Wang; Teng Li; Kunlun Chen; Songchao Li; Shaojin Zhang
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

5.  A functional variant of SHARPIN confers increased risk of late-onset Alzheimer's disease.

Authors:  Yuya Asanomi; Daichi Shigemizu; Shintaro Akiyama; Akinori Miyashita; Risa Mitsumori; Norikazu Hara; Takeshi Ikeuchi; Shumpei Niida; Kouichi Ozaki
Journal:  J Hum Genet       Date:  2021-11-05       Impact factor: 3.172

6.  Transcriptomic Profiling of Circular RNAs in the Goat Rumen During Fetal and Prepubertal Period.

Authors:  Tao Zhong; Cheng Wang; Meng Wang; Siyuan Zhan; Aline Freitas-de-Melo; Linjie Wang; Jiaxue Cao; Dinghui Dai; Jiazhong Guo; Li Li; Hongping Zhang; Lili Niu
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

7.  Roles of Rufy3 in experimental subarachnoid hemorrhage-induced early brain injury via accelerating neuronal axon repair and synaptic plasticity.

Authors:  Yang Wang; Jianguo Xu; Wanchun You; Haitao Shen; Xiang Li; Zhengquan Yu; Haiying Li; Gang Chen
Journal:  Mol Brain       Date:  2022-04-23       Impact factor: 4.399

8.  Identification and characterization of four immune-related signatures in keloid.

Authors:  Xiaoxiang Wang; Bo Liang; Jiehua Li; Xiaobing Pi; Peng Zhang; Xinzhu Zhou; Xiaodong Chen; Sitong Zhou; Ronghua Yang
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 9.  Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.

Authors:  Radmila Sparić; Mladen Andjić; Ivana Babović; Lazar Nejković; Milena Mitrović; Jelena Štulić; Miljan Pupovac; Andrea Tinelli
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

10.  TRPM2, PDLIM5, BCL3, CD14, GBA Genes as Feasible Markers for Premature Coronary Heart Disease Risk.

Authors:  Kriengchai Prasongsukarn; Wilanee Dechkhajorn; Surachet Benjathummarak; Yaowapa Maneerat
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.